Search alternatives:
significant prediction » significant reduction (Expand Search), significant predictor (Expand Search), significant predictive (Expand Search)
prediction based » prediction model (Expand Search)
mean decrease » a decrease (Expand Search)
gap decrease » a decrease (Expand Search), gain decreased (Expand Search), step decrease (Expand Search)
significant prediction » significant reduction (Expand Search), significant predictor (Expand Search), significant predictive (Expand Search)
prediction based » prediction model (Expand Search)
mean decrease » a decrease (Expand Search)
gap decrease » a decrease (Expand Search), gain decreased (Expand Search), step decrease (Expand Search)
-
81
Mean uncertainty of <i>boro</i> rice yields estimated by random forest model from 2002–2021.
Published 2024Subjects: -
82
-
83
-
84
-
85
-
86
-
87
-
88
-
89
-
90
-
91
Image 1_Construction of a clinically significant prostate cancer risk prediction model based on traditional diagnostic methods.tif
Published 2024“…Objectives<p>to construct a prediction model for clinically significant prostate cancer (csPCa) based on prostate-specific antigen (PSA) levels, digital rectal examination (DRE), and transrectal ultrasonography (TRUS).…”
-
92
-
93
-
94
-
95
-
96
-
97
-
98
Image_3_Prediction of clinically significant prostate cancer with a multimodal MRI-based radiomics nomogram.tif
Published 2022“…Objective<p>To develop and validate a multimodal MRI-based radiomics nomogram for predicting clinically significant prostate cancer (CS-PCa).…”
-
99
Table_1_Prediction of clinically significant prostate cancer with a multimodal MRI-based radiomics nomogram.docx
Published 2022“…Objective<p>To develop and validate a multimodal MRI-based radiomics nomogram for predicting clinically significant prostate cancer (CS-PCa).…”
-
100
Table_3_Prediction of clinically significant prostate cancer with a multimodal MRI-based radiomics nomogram.docx
Published 2022“…Objective<p>To develop and validate a multimodal MRI-based radiomics nomogram for predicting clinically significant prostate cancer (CS-PCa).…”